Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma, and cerebrospinal fluid.
Diphenylhydantoin, primidone, and phenobarbital were determined in saliva and plasma of 164 patients by gas-liquid chromatography. The saliva ratio was about one-tenth in patients on diphenylhydantoin, 0.32-0.38 on phenobarbital alone and with other drugs, 0.97 and 0.96 on primidone alone and with other drugs. The S/P ratio of phenobarbital was similar in patients treated with primidone alone or with co-medication. For diphenylhydantoin and primidone, the S/P and CSF/plasma ratio were similar; for phenobarbital the S/P ratio was lower due to the difference in pH of saliva and CSF. Thus the concentration in saliva serves as a measure of the nonprotein-bound or free concentration in plasma with the advantage that saliva is easy to obtain. Co-medication does not change the S/P ratio for the three drugs studied. The high correlation between levels in plasma and in saliva allows the plasma levels to be predicted from the concentration in saliva.
D006801:Humans; D007700:Kinetics; D010634:Phenobarbital / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D010672:Phenytoin / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D011324:Primidone / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D012463:Saliva / Q000032:analysis
D011324:Primidone; D010672:Phenytoin; D010634:Phenobarbital